547 related articles for article (PubMed ID: 9759856)
1. Gamma 3 gene-disrupted mice selectively deficient in the dominant IgG subclass made to bacterial polysaccharides undergo normal isotype switching after immunization with polysaccharide-protein conjugate vaccines.
Shapiro DA; Threadgill DS; Copfer MJ; Corey DA; McCool TL; McCormick LL; Magnuson TR; Greenspan NS; Schreiber JR
J Immunol; 1998 Oct; 161(7):3393-9. PubMed ID: 9759856
[TBL] [Abstract][Full Text] [Related]
2. Gamma 3 gene-disrupted mice selectively deficient in the dominant IgG subclass made to bacterial polysaccharides. II. Increased susceptibility to fatal pneumococcal sepsis due to absence of anti-polysaccharide IgG3 is corrected by induction of anti-polysaccharide IgG1.
McLay J; Leonard E; Petersen S; Shapiro D; Greenspan NS; Schreiber JR
J Immunol; 2002 Apr; 168(7):3437-43. PubMed ID: 11907102
[TBL] [Abstract][Full Text] [Related]
3. IgG subclass deficiencies and recurrent pyogenic infections, unresponsiveness against bacterial polysaccharide antigens.
Kuijpers TW; Weening RS; Out TA
Allergol Immunopathol (Madr); 1992; 20(1):28-34. PubMed ID: 1509985
[TBL] [Abstract][Full Text] [Related]
4. Clonal characterization of the human IgG antibody repertoire to Haemophilus influenzae type b polysaccharide. V. In vivo expression of individual antibody clones is dependent on Ig CH haplotypes and the categories of antigen.
Chung GH; Scott MG; Kim KH; Kearney J; Siber GR; Ambrosino DM; Nahm MH
J Immunol; 1993 Oct; 151(8):4352-61. PubMed ID: 8409407
[TBL] [Abstract][Full Text] [Related]
5. IgG subclasses and avidity of antibodies to polysaccharide antigens in allogeneic BMT recipients after vaccination with pneumococcal polysaccharide and Haemophilus influenzae type b conjugate vaccines.
Parkkali T; Käyhty H; Anttila M; Ruutu T; Wuorimaa T; Soininen A; Volin L; Ruutu P
Bone Marrow Transplant; 1999 Sep; 24(6):671-8. PubMed ID: 10490735
[TBL] [Abstract][Full Text] [Related]
6. In vivo polysaccharide-specific IgG isotype responses to intact Streptococcus pneumoniae are T cell dependent and require CD40- and B7-ligand interactions.
Wu ZQ; Vos Q; Shen Y; Lees A; Wilson SR; Briles DE; Gause WC; Mond JJ; Snapper CM
J Immunol; 1999 Jul; 163(2):659-67. PubMed ID: 10395655
[TBL] [Abstract][Full Text] [Related]
7. New meningococcal C polysaccharide-tetanus toxoid conjugate Physico-chemical and immunological characterization.
Cuello M; Cabrera O; Martinez I; Del Campo JM; Camaraza MA; Sotolongo F; Pérez O; Sierra G
Vaccine; 2007 Feb; 25(10):1798-805. PubMed ID: 17240485
[TBL] [Abstract][Full Text] [Related]
8. B cells genetically deficient in the c-Rel transactivation domain have selective defects in germline CH transcription and Ig class switching.
Zelazowski P; Carrasco D; Rosas FR; Moorman MA; Bravo R; Snapper CM
J Immunol; 1997 Oct; 159(7):3133-9. PubMed ID: 9317110
[TBL] [Abstract][Full Text] [Related]
9. Immunization of humans with polysaccharide vaccines induces systemic, predominantly polymeric IgA2-subclass antibody responses.
Tarkowski A; Lue C; Moldoveanu Z; Kiyono H; McGhee JR; Mestecky J
J Immunol; 1990 May; 144(10):3770-8. PubMed ID: 2110213
[TBL] [Abstract][Full Text] [Related]
10. Subclass distribution of human antibodies to Haemophilus influenzae type b capsular polysaccharide.
Shackelford PG; Granoff DM; Nelson SJ; Scott MG; Smith DS; Nahm MH
J Immunol; 1987 Jan; 138(2):587-92. PubMed ID: 3491852
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the human immune response to a Pseudomonas aeruginosa O-polysaccharide-toxin A conjugate vaccine.
Cryz SJ; Sadoff JC; Ohman D; Fürer E
J Lab Clin Med; 1988 Jun; 111(6):701-7. PubMed ID: 3131471
[TBL] [Abstract][Full Text] [Related]
12. Enhanced IgG1 and IgG3 responses to pneumococcal polysaccharides in isolated IgA deficiency.
Roberton DM; Björkander J; Henrichsen J; Söderström T; Hanson LA
Clin Exp Immunol; 1989 Feb; 75(2):201-5. PubMed ID: 2702775
[TBL] [Abstract][Full Text] [Related]
13. IL-12 enhances antibody responses to T-independent polysaccharide vaccines in the absence of T and NK cells.
Buchanan RM; Arulanandam BP; Metzger DW
J Immunol; 1998 Nov; 161(10):5525-33. PubMed ID: 9820529
[TBL] [Abstract][Full Text] [Related]
14. Distinct approaches to investigate the importance of the murine 4-1BB 4-1BBL interaction in the antibody response to Streptococcus pneumoniae.
Moens L; Jeurissen A; Mittler RS; Wuyts G; Michiels G; Boon L; Ceuppens JL; Bossuyt X
J Leukoc Biol; 2007 Sep; 82(3):638-44. PubMed ID: 17550973
[TBL] [Abstract][Full Text] [Related]
15. The role of cytophilic IgG3 antibody in T cell-mediated resistance to infection with the extracellular bacterium, Pseudomonas aeruginosa.
Markham RB; Pier GB; Schreiber JR
J Immunol; 1991 Jan; 146(1):316-20. PubMed ID: 1898604
[TBL] [Abstract][Full Text] [Related]
16. Type 6 and 19 pneumococcal polysaccharides coupled to erythrocytes elicit pneumococcal cell wall-specific primary IgM responses and capsular polysaccharide-specific secondary IgG responses.
Milligan GN; Fairchild RL; Sterner KE; Braley-Mullen H
Eur J Immunol; 1990 Mar; 20(3):595-603. PubMed ID: 2318251
[TBL] [Abstract][Full Text] [Related]
17. Serotype of Streptococcus pneumoniae capsular polysaccharide can modify the Th1/Th2 cytokine profile and IgG subclass response to pneumococal-CRM(197) conjugate vaccines in a murine model.
Mawas F; Feavers IM; Corbel MJ
Vaccine; 2000 Dec; 19(9-10):1159-66. PubMed ID: 11137252
[TBL] [Abstract][Full Text] [Related]
18. Human IgG and IgA subclass response following immunization with a polyvalent Klebsiella capsular polysaccharide vaccine.
Cryz SJ; Cross AS; Sadoff GC; Que JU
Eur J Immunol; 1988 Dec; 18(12):2073-5. PubMed ID: 3220104
[TBL] [Abstract][Full Text] [Related]
19. CpG oligodeoxynucleotides act as adjuvants for pneumococcal polysaccharide-protein conjugate vaccines and enhance antipolysaccharide immunoglobulin G2a (IgG2a) and IgG3 antibodies.
Chu RS; McCool T; Greenspan NS; Schreiber JR; Harding CV
Infect Immun; 2000 Mar; 68(3):1450-6. PubMed ID: 10678959
[TBL] [Abstract][Full Text] [Related]
20. T-cell dependent and T-cell independent antibody response to bacterial polysaccharides in patients with IgG2 deficiency.
Bartmann P; Freihorst J; Seger R; Schmitt M; Wahn U; Wahn V; Jager H
Immunodeficiency; 1993; 4(1-4):59-61. PubMed ID: 8167735
[No Abstract] [Full Text] [Related]
[Next] [New Search]
